SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19

EDUARDO AGÜERA MORALESJAVIER CABALLERO VILLARRASOBEGOÑA MARIA ESCRIBANO DURÁN2026-01-292026-01-29202210.1007/s00415-022-11237-12-s2.0-85133466834https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/35183NeurologyNeurology (clinical)NeurologyNeurology (clinical)SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19review article